| Amgen (AMGN) |
United States |
$104.470B |
11.81 |
| Gilead Sciences (GILD) |
United States |
$85.278B |
10.35 |
| Celgene (CELG) |
United States |
$67.169B |
11.38 |
| Illumina (ILMN) |
United States |
$45.930B |
53.23 |
| Biogen (BIIB) |
United States |
$44.025B |
8.36 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$43.994B |
53.18 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$34.155B |
16.05 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$28.512B |
16.14 |
| Incyte (INCY) |
United States |
$17.530B |
71.09 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.950B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$12.511B |
0.00 |
| Seattle Genetics (SGEN) |
United States |
$11.153B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$8.999B |
47.71 |
| Sarepta Therapeutics (SRPT) |
United States |
$8.961B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$8.614B |
28.30 |
| Bio-Techne Corp (TECH) |
United States |
$7.491B |
51.11 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$7.344B |
0.00 |
| Moderna (MRNA) |
United States |
$7.182B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$6.772B |
0.00 |
| Guardant Health (GH) |
United States |
$6.708B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.144B |
15.66 |
| Galapagos (GLPG) |
Belgium |
$6.114B |
0.00 |
| Array BioPharma (ARRY) |
United States |
$6.007B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$5.905B |
0.00 |
| Amarin (AMRN) |
Ireland |
$5.693B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$5.434B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$4.420B |
0.00 |
| Spark Therapeutics (ONCE) |
United States |
$4.238B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$4.137B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.758B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.743B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.582B |
22.75 |
| Allogene Therapeutics (ALLO) |
United States |
$3.440B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$3.380B |
0.00 |
| MorphoSys AG Unsponsored ADR (MOR) |
Germany |
$3.327B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.286B |
0.00 |
| Repligen (RGEN) |
United States |
$3.252B |
81.01 |
| Immunomedics (IMMU) |
United States |
$2.835B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.807B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$2.766B |
0.00 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$2.745B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$2.648B |
5.38 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.632B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.616B |
0.00 |
| Medicines (MDCO) |
United States |
$2.578B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.381B |
0.00 |
| MyoKardia (MYOK) |
United States |
$2.295B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.242B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.230B |
18.47 |
| Emergent Biosolutions (EBS) |
United States |
$2.224B |
19.32 |
| Acceleron Pharma (XLRN) |
United States |
$2.216B |
0.00 |
| Lion Biotechnologies (IOVA) |
United States |
$2.131B |
0.00 |
| Insmed (INSM) |
United States |
$2.045B |
0.00 |
| NeoGenomics (NEO) |
United States |
$2.029B |
132.81 |
| AnaptysBio (ANAB) |
United States |
$2.019B |
0.00 |
| Genomic Health (GHDX) |
United States |
$2.005B |
42.58 |
| Denali Therapeutics (DNLI) |
United States |
$1.979B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$1.967B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$1.958B |
0.00 |
| Allakos (ALLK) |
United States |
$1.913B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.797B |
17.88 |
| Audentes Therapeutics (BOLD) |
United States |
$1.687B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.672B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.659B |
0.00 |
| Orchard Therapeutics Sponsored ADR (ORTX) |
United Kingdom |
$1.598B |
0.00 |
| Zai Lab Unsponsored ADR (ZLAB) |
China |
$1.529B |
0.00 |
| Innoviva (INVA) |
United States |
$1.469B |
4.06 |
| Coherus BioSciences (CHRS) |
United States |
$1.412B |
0.00 |
| Cambrex (CBM) |
United States |
$1.402B |
17.73 |
| Gossamer Bio (GOSS) |
United States |
$1.355B |
0.00 |
| Rubius Therapeutics (RUBY) |
United States |
$1.346B |
0.00 |
| Alector (ALEC) |
United States |
$1.343B |
0.00 |
| Aimmune Therapeutics (AIMT) |
United States |
$1.266B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$1.237B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$1.209B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$1.208B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.174B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.121B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$1.092B |
0.00 |
| Atara Biotherapeutics (ATRA) |
United States |
$1.075B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.069B |
0.00 |
| Codexis (CDXS) |
United States |
$1.045B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$1.001B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$0.987B |
0.00 |
| Athenex (ATNX) |
United States |
$0.939B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$0.924B |
0.00 |
| GENFIT Unsponsored ADR (GNFT) |
France |
$0.912B |
0.00 |
| InflaRx (IFRX) |
Germany |
$0.912B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$0.904B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$0.895B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.887B |
0.00 |
| Myovant Sciences (MYOV) |
United Kingdom |
$0.880B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.871B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.862B |
40.70 |
| Kiniksa Pharmaceuticals (KNSA) |
Bermuda |
$0.857B |
0.00 |
| Nightstar Therapeutics Sponsored ADR (NITE) |
United Kingdom |
$0.854B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$0.853B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.848B |
0.00 |
| Autolus Therapeutics Sponsored ADR (AUTL) |
United Kingdom |
$0.846B |
0.00 |
| Inotek Pharmaceuticals (RCKT) |
United States |
$0.843B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.825B |
14.63 |
| Axsome Therapeutics (AXSM) |
United States |
$0.824B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.812B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.779B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$0.742B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$0.729B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$0.721B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.718B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$0.715B |
0.00 |
| Cellectis (CLLS) |
France |
$0.715B |
0.00 |
| CORTEXYME INC (CRTX) |
United States |
$0.712B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.710B |
0.00 |
| Vericel (VCEL) |
United States |
$0.692B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.691B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.685B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.679B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.664B |
7.76 |
| Kura Oncology (KURA) |
United States |
$0.654B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.654B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.629B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$0.615B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.597B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.585B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.580B |
0.00 |
| Heska (HSKA) |
United States |
$0.580B |
59.37 |
| ObsEva SA (OBSV) |
Switzerland |
$0.574B |
0.00 |
| Magenta Therapeutics (MGTA) |
United States |
$0.571B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$0.566B |
0.00 |
| DBV Technologies (DBVT) |
France |
$0.550B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.541B |
18.49 |
| Kaleido Biosciences (KLDO) |
|
$0.524B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.511B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.510B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.502B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.502B |
0.00 |
| Synthorx (THOR) |
United States |
$0.499B |
0.00 |
| MediciNova (MNOV) |
United States |
$0.494B |
0.00 |
| NuCana Sponsored ADR (NCNA) |
United Kingdom |
$0.489B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.489B |
8.61 |
| Mesoblast (MESO) |
Australia |
$0.478B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.477B |
0.00 |
| Replimune (REPL) |
United States |
$0.471B |
0.00 |
| MILESTONE PHARM (MIST) |
Canada |
$0.470B |
0.00 |
| Krystal Biotech (KRYS) |
United States |
$0.469B |
0.00 |
| NEXTCURE INC (NXTC) |
United States |
$0.437B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.429B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.415B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.405B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.399B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.394B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.384B |
0.00 |
| Agenus (AGEN) |
United States |
$0.384B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.384B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.378B |
0.00 |
| AVROBIO (AVRO) |
United States |
$0.376B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.376B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.374B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.371B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.365B |
0.00 |
| UNITY Biotechnology (UBX) |
|
$0.363B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.357B |
8.46 |
| Biofrontera AG Sponsored ADR (BFRA) |
Germany |
$0.357B |
0.00 |
| Kodiak Sciences (KOD) |
United States |
$0.352B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.346B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.340B |
21.87 |
| Stealth BioTherapeutics Sponsored ADR (MITO) |
United States |
$0.340B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.340B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.332B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.326B |
0.00 |
| AXCELLA HEALTH (AXLA) |
United States |
$0.326B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.326B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.325B |
0.00 |
| Kezar Life Sciences (KZR) |
United States |
$0.323B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.322B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.320B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.309B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.299B |
0.00 |
| Geron (GERN) |
United States |
$0.289B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.281B |
0.00 |
| ResTORbio (TORC) |
United States |
$0.273B |
0.00 |
| Constellation Pharmaceuticals (CNST) |
United States |
$0.272B |
0.00 |
| Athersys (ATHX) |
United States |
$0.270B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.260B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.259B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.258B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.256B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.255B |
0.00 |
| Enochian BioSciences (ENOB) |
United States |
$0.250B |
0.00 |
| Evelo Biosciences (EVLO) |
United States |
$0.245B |
0.00 |
| Celcuity (CELC) |
United States |
$0.240B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.238B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.236B |
0.00 |
| Urovant Sciences (UROV) |
United States |
$0.231B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.229B |
8.88 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.222B |
0.00 |
| OvaScience (MLND) |
United States |
$0.221B |
0.00 |
| Eiger BioPharmaceuticals (EIGR) |
United States |
$0.220B |
0.00 |
| MannKind (MNKD) |
United States |
$0.220B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.217B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.213B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.213B |
0.00 |
| Cerecor (CERC) |
United States |
$0.213B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.213B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.208B |
0.00 |
| Chiasma (CHMA) |
United States |
$0.206B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.205B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.201B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.199B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.199B |
0.00 |
| HOOKIPA PHARMA (HOOK) |
United States |
$0.198B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.197B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.195B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.193B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.193B |
0.00 |
| Neothetics (EVFM) |
United States |
$0.191B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.177B |
0.00 |
| Intec Pharma (NTEC) |
Israel |
$0.175B |
0.00 |
| Gamida Cell (GMDA) |
Israel |
$0.174B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.174B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.173B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.171B |
0.00 |
| APPLIED THERAPT (APLT) |
United States |
$0.171B |
0.00 |
| BioXcel Therapeutics (BTAI) |
United States |
$0.170B |
0.00 |
| XOMA (XOMA) |
United States |
$0.166B |
0.00 |
| Axovant Sciences (AXGT) |
United Kingdom |
$0.164B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.163B |
0.00 |
| Anavex Life Sciences (AVXL) |
United States |
$0.162B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.161B |
0.00 |
| TREVI THERAPTCS (TRVI) |
United States |
$0.160B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.159B |
9.19 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.157B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.156B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.153B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.147B |
0.00 |
| Novavax (NVAX) |
United States |
$0.144B |
0.00 |
| Provention Bio (PRVB) |
United States |
$0.142B |
0.00 |
| Mustang Bio (MBIO) |
United States |
$0.138B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.136B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.136B |
0.00 |
| Erytech Pharma SA Sponsored ADR (ERYP) |
France |
$0.127B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.121B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
United States |
$0.118B |
0.00 |
| Trevena (TRVN) |
United States |
$0.113B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.113B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.112B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.111B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.109B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.109B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.109B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.108B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.107B |
0.00 |
| Equillium (EQ) |
United States |
$0.105B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.105B |
0.00 |
| NantKwest (NK) |
United States |
$0.105B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.102B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.099B |
0.00 |
| Verastem (VSTM) |
United States |
$0.098B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.097B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.095B |
0.00 |
| Allena Pharmaceuticals (ALNA) |
United States |
$0.094B |
0.00 |
| Tiziana Life Sciences Sponsored ADR (TLSA) |
United Kingdom |
$0.092B |
0.00 |
| Aptose Biosciences (APTO) |
Canada |
$0.089B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.087B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.086B |
0.00 |
| Cohbar (CWBR) |
United States |
$0.084B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.084B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.083B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$0.082B |
0.00 |
| Brainstorm Cell Therapeutics (BCLI) |
United States |
$0.080B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.080B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.079B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.076B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.074B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.072B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.070B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.070B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.069B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.069B |
38.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.068B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.068B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.067B |
0.00 |
| ScPharmaceuticals (SCPH) |
United States |
$0.066B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.066B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.062B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.062B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.062B |
0.00 |
| Apricus Biosciences (SEEL) |
United States |
$0.056B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.056B |
0.00 |
| Ophthotech (ISEE) |
United States |
$0.055B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.052B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.052B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.051B |
0.00 |
| Moleculin Biotech (MBRX) |
United States |
$0.050B |
0.00 |
| Curis (CRIS) |
United States |
$0.049B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.048B |
0.00 |
| INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.048B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.046B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.046B |
0.00 |
| AZURRX BIOPHARM (AZRX) |
United States |
$0.045B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.045B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.045B |
0.00 |
| Bellerophon Therapeutics (BLPH) |
United States |
$0.044B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.044B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.044B |
0.00 |
| BiondVax Pharmaceuticals (BVXV) |
Israel |
$0.043B |
0.00 |
| Celsion (CLSN) |
United States |
$0.043B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.041B |
0.00 |
| Sienna Biopharmaceuticals (SNNA) |
United States |
$0.040B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.039B |
0.00 |
| Anchiano Therapeutics Sponsored ADR (ANCN) |
Israel |
$0.037B |
0.00 |
| Akari Therapeutics (AKTX) |
United Kingdom |
$0.036B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.035B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.034B |
0.00 |
| Edge Therapeutics (PDSB) |
United States |
$0.034B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.034B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.033B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.033B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.032B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.031B |
0.00 |
| Caladrius Biosciences (CLBS) |
United States |
$0.031B |
0.00 |
| Motif Bio Plc (MTFB) |
United States |
$0.027B |
0.00 |
| Vical (VICL) |
United States |
$0.026B |
0.00 |
| GENPREX INC (GNPX) |
United States |
$0.025B |
0.00 |
| Sophiris Bio (SPHS) |
United States |
$0.024B |
0.00 |
| GTx (GTXI) |
United States |
$0.024B |
0.00 |
| Adial Pharmaceuticals (ADIL) |
United States |
$0.023B |
0.00 |
| Bison Capital Acquisition (XYN) |
China |
$0.022B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.022B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.020B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.019B |
0.00 |
| CytRx (CYTR) |
United States |
$0.019B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.019B |
0.00 |
| Fibrocell Science Inc (FCSC) |
United States |
$0.018B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.018B |
0.00 |
| Novelion Therapeutics (NVLN) |
Canada |
$0.017B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.017B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.016B |
0.00 |
| Histogenics (HSGX) |
United States |
$0.016B |
0.00 |
| OncoSec Medical (ONCS) |
United States |
$0.016B |
0.00 |
| Aileron Therapeutics (ALRN) |
United States |
$0.016B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.015B |
0.00 |
| Gemphire Therapeutics (GEMP) |
United States |
$0.015B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.015B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.015B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.013B |
0.00 |
| IMMURON LTD (IMRN) |
Australia |
$0.013B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.012B |
0.00 |
| RestorGenex (DFFN) |
United States |
$0.012B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.012B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.012B |
0.00 |
| Vital Therapies (IMUX) |
United States |
$0.012B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.011B |
0.00 |
| Dare Bioscience (DARE) |
United States |
$0.010B |
0.00 |
| Neuralstem (CUR) |
United States |
$0.009B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.009B |
0.00 |
| Therapix Biosciences (TRPX) |
Israel |
$0.009B |
0.00 |
| Proteon Therapeutics (PRTO) |
United States |
$0.008B |
0.00 |
| ARCA Biopharma (ABIO) |
United States |
$0.008B |
0.00 |
| Flex Pharma (FLKS) |
United States |
$0.008B |
0.00 |
| Cytori Therapeutics Inc (CYTX) |
United States |
$0.006B |
0.00 |
| Stellar Biotechnologies (SBOT) |
United States |
$0.006B |
0.00 |
| Alliqua BioMedical (ADYX) |
United States |
$0.006B |
0.00 |
| ContraVir Pharmaceuticals Inc (CTRV) |
United States |
$0.005B |
0.00 |
| Cellect Biotechnology (APOP) |
Israel |
$0.004B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$0.000B |
0.00 |
